Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Venclexta
Venclexta
How AbbVie Could Make an Entry Into This Rapidly Growing Drug Market
How AbbVie Could Make an Entry Into This Rapidly Growing Drug Market
Motley Fool
AbbVie
Roche
Venclexta
MDS
breakthrough therapy
Flag link:
In next-gen BTK battle, AbbVie and J&J tout pivotal data backing Imbruvica as a combo treatment
In next-gen BTK battle, AbbVie and J&J tout pivotal data backing Imbruvica as a combo treatment
Endpoints
AstraZeneca
JNJ
AbbVie
clinical trials
CLL
Gazyva
Imbruvica
Venclexta
Flag link:
FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
Pharmaforum
Roche
Genentech
AbbVie
Venclexta
AML
clinical trials
FDA
Flag link:
EHA: AbbVie, Roche cement Venclexta's place in AML with survival win
EHA: AbbVie, Roche cement Venclexta's place in AML with survival win
Fierce Pharma
AbbVie
Roche
Venclexta
AML
EHA
Flag link:
AbbVie announces positive topline results from phase 3 trial of VENCLEXTA, Azacitidine combo in AML
AbbVie announces positive topline results from phase 3 trial of VENCLEXTA, Azacitidine combo in AML
Pharmaceutical Business Review
AbbVie
Venclexta
azacitidine
clinical trials
AML
Flag link:
AbbVie, Roche's Venclexta nails confirmatory combo trial in AML after flopping earlier study
AbbVie, Roche's Venclexta nails confirmatory combo trial in AML after flopping earlier study
Fierce Pharma
AbbVie
Roche
Venclexta
AML
clinical trials
Flag link:
AbbVie, Roche's Venclexta endangers AML approval with flopped confirmatory trial
AbbVie, Roche's Venclexta endangers AML approval with flopped confirmatory trial
Fierce Pharma
AbbVie
Roche
Venclexta
AML
blood cancer
FDA
Flag link:
ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL
ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL
Fierce Pharma
AbbVie
Roche
CLL
ASH2019
Venclexta
Flag link:
Roche and Celgene set for battle in acute myelogenous leukaemia
Roche and Celgene set for battle in acute myelogenous leukaemia
EP Vantage
Celgene
Roche
AML
acute myeloid leukemia
CC-486
Venclexta
Flag link:
5 Things You Need to Know From AbbVie's Q2 Earnings Results
5 Things You Need to Know From AbbVie's Q2 Earnings Results
Motley Fool
AbbVie
Humira
Venclexta
Imbruvica
hepatitis C
earnings
Flag link:
FDA lifts hold on AbbVie multiple myeloma study
FDA lifts hold on AbbVie multiple myeloma study
Biopharma Dive
FDA
AbbVie
Venclexta
clinical trials
Multiple Myeloma
Flag link:
AbbVie gets a green light to resume recruiting patients for one myeloma study — but Venclexta remains under a cloud
AbbVie gets a green light to resume recruiting patients for one myeloma study — but Venclexta remains under a cloud
Endpoints
AbbVie
Venclexta
Multiple Myeloma
FDA
clinical trials
Flag link:
ASCO Soundbites, vol. 3: Real-time approvals, Pfizer's second rodeo and 'the busiest ASCO ever'
ASCO Soundbites, vol. 3: Real-time approvals, Pfizer's second rodeo and 'the busiest ASCO ever'
Fierce Pharma
ASCO 2019
Merck
Keytruda
FDA
Pfizer
AstraZeneca
Regeneron
Libtayo
Venclexta
Gazyva
Flag link:
AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva
AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva
Fierce Pharma
AbbVie
Roche
Venclexta
CLL
small lymphocytic leukemia
Flag link:
2 Things Investors Are Missing About AbbVie
2 Things Investors Are Missing About AbbVie
Motley Fool
AbbVie
ABBV-599
Humira
risankizumab
upadacatinib
Imbruvica
Venclexta
Orilissa
Flag link:
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
CP Wire
Genentech
Roche
AbbVie
chronic lymphocytic leukemia
Gazyva
Venclexta
Flag link:
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
Genentech
Roche
AbbVie
chronic lymphocytic leukemia
Gazyva
Venclexta
Flag link:
AbbVie’s cancer drug Venclexta blocks diabetes in mice by targeting beta cell ‘senescence’
AbbVie’s cancer drug Venclexta blocks diabetes in mice by targeting beta cell ‘senescence’
Fierce Biotech
senescence
Venclexta
type 1 diabetes
AbbVie
Flag link:
AbbVie, Roche aim to face down Pfizer with Venclexta’s move into AML arena
AbbVie, Roche aim to face down Pfizer with Venclexta’s move into AML arena
Fierce Pharma
AbbVie
Venclexta
Roche
AML
Flag link:
FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia
FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia
Yahoo/Guru Focus
Roche
Genentech
Venclexta
FDA
AML
acute myeloid leukemia
Flag link:
Pages
1
2
next ›
last »